The role of proton beam therapy for patients with intermediate- and high-risk prostate cancer.

被引：0
|
作者：
Arimura, Takeshi
Kondo, Naoaki
Matsukawa, Kyoko
Wada, Kiyotaka
Kitano, Ikumi
Chuman, Ikuko
Nagata, Ichiro
Ogino, Takashi
机构：
[1] Medipolis Proton Therapy & Res Ctr, Ibusuki, Kagoshima, Japan
[2] Proton Therapy & Res Ctr, Ibusuki, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.97
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
97
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Comorbidity and androgen deprivation therapy use in men undergoing high-dose radiation for unfavorable intermediate- and high-risk prostate cancer.
    Dyer, Michael A.
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian Joseph
    D'Amico, Anthony V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [22] Stereotactic Ablative Body Radiotherapy for Intermediate- or High-Risk Prostate Cancer
    Loblaw, Andrew
    [J]. CANCER JOURNAL, 2020, 26 (01): : 38 - 42
  • [23] Robotic Extended Pelvic Lymphadenectomy for Intermediate- and High-Risk Prostate Cancer
    Yuh, Bertram E.
    Ruel, Nora H.
    Mejia, Rosa
    Wilson, Chelsea M.
    Wilson, Timothy G.
    [J]. EUROPEAN UROLOGY, 2012, 61 (05) : 1004 - 1010
  • [24] TREATMENT RESULTS OF PDR BRACHYTHERAPY COMBINED WITH EXTERNAL BEAM RADIOTHERAPY IN 106 PATIENTS WITH INTERMEDIATE- TO HIGH-RISK PROSTATE CANCER
    Pieters, Bradley R.
    Geijsen, Elisabeth D.
    Koedooder, Kees
    Blank, Leo E. C. M.
    Rezaie, Elisa
    van der Grient, Johan N. B.
    de Reijke, Theo M.
    Koning, Caro C. E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1037 - 1042
  • [25] Hypofractionated versus conventional radiotherapy in intermediate- to high-risk prostate cancer
    Guo, W.
    Gao, X. S.
    Gu, X. B.
    Ma, M. W.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S716 - S716
  • [26] Five-Year Outcomes of Proton Therapy in Localized Prostate Cancer on 3 Prospective Trials for Low-, Intermediate-, and High-Risk Prostate Cancer
    Mendenhall, N. P.
    Hoppe, B. S.
    Morris, C. G.
    Nichols, R. C.
    Mendenhall, W. M.
    Su, Z.
    Li, Z.
    Williams, C. R.
    Costa, J.
    Henderson, R. H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S155 - S155
  • [27] Results of Scanning Beam Proton Therapy (SCBT) for the Treatment of Patients With High-Risk Prostate Cancer
    Choi, S.
    Nguyen, Q.
    Pugh, T. J.
    Mahmood, U.
    McGuire, S. E.
    Hoffman, K. E.
    Frank, S. J.
    Kuban, D. A.
    Lee, A. K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E243 - E244
  • [28] Brachytherapy Increased use in patients with intermediate- and high-risk prostate cancers
    Ali, Sanna
    Esper, Peg
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2021, 25 (03) : 321 - 328
  • [29] Impact of hormone therapy when combined with external beam radiotherapy for early-stage, intermediate-, or high-risk prostate cancer
    Jani, AB
    Basu, A
    Abdalla, I
    Connell, PP
    Krauz, L
    Vijayakumar, S
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : 382 - 385
  • [30] Quantitative imaging parameters to predict local staging of prostate cancer in intermediate- to high-risk patients
    Laudicella, R.
    Skawran, S.
    Ferraro, D. A.
    Muhlematter, U.
    Maurer, A.
    Grunig, H.
    Donati, O.
    Eberli, D.
    Burger, I. A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S206 - S206
12345